Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06375733
Status:
RECRUITING
Last Update Posted:
2024-04-19
First Post:
2024-03-05
Brief Title:
A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL
Sponsor:
Zhejiang Genfleet Therapeutics Co Ltd
Organization:
Genfleet Therapeutics Shanghai Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Large B-cell Lymphoma |
Keywords:
| Name | View |
|---|---|
| relapsed or refractory diffuse large B-cell lymphoma DLBCL | View |